PTC Therapeutics price target lowered at Cantor Fitzgerald, a top pick in 2025
Cantor Fitzgerald lowered the firm’s price target on PTC Therapeutics (PTCT) to $76 from $80 and keeps an Overweight rating on the shares. The ...
IDEAYA Biosciences (NASDAQ:IDYA) Receives “Overweight” Rating from Cantor Fitzgerald
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...
Morningstar1mon
Cantor Fitzgerald Large Cap Fcs Cl A
Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90 ...
MicroStrategy price target raised to $613 from $581 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $613 from $581 and keeps an Overweight rating on the shares.
Benzinga.com1mon
Financial Crime Weekly: Cantor Fitzgerald Charged With Violating AntiFraud Provisions, Ex-ComTech CEO Charged With Insider Trading
Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...
NBC Washington1mon
SEC charges Cantor Fitzgerald, led by Trump's Commerce pick, with breaking securities laws
The Securities and Exchange Commission charged Cantor Fitzgerald with violating laws related to disclosures by so-called blank-check companies before they raise money from the public. Cantor ...
Reuters1mon
Cantor Fitzgerald pays $6.75 million to settle SEC charges over misleading SPAC disclosures
WASHINGTON, Dec 12 (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75 million penalty to settle Securities and Exchange Commission charges that it misled investors in ...
Nasdaq7d
Zevra Therapeutics assumed with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...
Morningstar1mon
Cantor Fitzgerald International Eq F
Cantor Fitzgerald International Eq Fund earns an Above Average Process Pillar rating. The primary contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.
What's Going On With Applied Digital Stock Wednesday?
Applied Digital Corp (NASDAQ:APLD) shares are trading lower Wednesday on the heels of the company's second-quarter financial ...